Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

New treatments for hair loss may target specific pathways and generate new hair follicles.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Licorice has many traditional health benefits, but more research is needed to fully support these claims.

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Dianabol boosts muscle growth but has serious health risks and legal issues.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.

Drugs can change hair growth and this is important because it can upset people.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Finasteride is more harmful to male reproductive health than minoxidil.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Bicalutamide may help treat female pattern hair loss.